Research
Protalix reports success in oral Gaucher treatment study Gali Weinreb
Protalix will now have to demonstrate that the enzyme can reach the bloodstream in controllable dosages, and influence the condition of a Gaucher disease patient.
Protalix Biotherapeutics Inc. today reported success in a Phase I clinical trial of its oral treatment of Gaucher's disease. The study found that oral glucocerebrosidase (GCD) was well-tolerated, and active enzyme was detected in patients' blood circulation.
Download Presentation
In collaboration with
Children’s Liver Foundation (Sukhbir Kaur)
THINK Foundation (Vinay Shetty)
Thalassemia and Sickle society, Hyderabad (Suman Singh )
DMC Hospital, Ludhiana (Ajit Sood)
SGPGI, Lucknow (Shubha Phadke, Anjurani)
Thalassemia Welfare Association, Chennai (Revathi Raj)
Attachment | Size |
---|---|
Thal with Hep C prevalence MARCH 2013.pptx | 100.88 KB |
FOOD ITEMS THAT CAN BE CONSUMED BY WILSON DISEASE PATIENTS (Reference National Institute of Nutrition 2017)
- DAIRY – Milk, curd, Khoa, Ghee, Cheese, Paneer
- Rice / Wheat / Jawar / Bajra / Makka / Ragi
- All vegetables
- All fruits
- Egg
- Fish Prawns
- Chicken
- Red meat – Mutton /Sheep / Beef
- Jaggery
- Tea / Coffee
- Spices except cumin, corianderseed, black pepper, mace
- Bengalgram Dal (Chola / Chana), Moong, Masoor, Urad dal,
- Mushrooms
AVOID